Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Study Shows Antibiotic Use Among Infants Can Be Reduced Without Adverse Effects Antibiotic stewardship programs not only reduced the number of prescriptions, but also cut down the number of days infants were prescribed to take them. May 24, 2024 Martha Garcia Add Your Comments Implementing an antibiotic reduction program in hospital neonatal intensive care units (NICUs) helps reduce the number and duration of antibiotic prescriptions among infants, according to the findings of a new study, which may have important implications for addressing the widespread overuse of the drugs and growing proliferation of antibiotic-resistant infections. Hospital NICU stewardship programs helped to reduce new prescriptions by 19% and reduced the duration of antibiotic prescriptions by 20%, according to a report published on May 20 in the journal Pediatrics. Antibiotics are one of the most frequently used drugs in NICUs. Broad spectrum antibiotics like Zithromax are commonly prescribed to protect infants at risk of infections. They are especially used to prevent sepsis; a severe infection that spreads quickly through the body, shuts down the organs and often leads to death. Infant Antibiotic Overuse Concerns Antibiotics are often prescribed to infants that are premature infants, have immature immune systems, or are more vulnerable to other infections. Additionally, if a mother experiences complications or infections during delivery, the infant may also be given antibiotics then as well. However, medical experts have raised serious concerns about the overuse of antibiotics among infants, which has been linked to the creation of drug-resistant bacteria, or superbugs. A recent U.N. report warned the evolution of superbugs poses a serious threat to human health. Research indicates that antibiotic overprescribing may increase colon cancer rates among young and older patients. The use of antibiotics in children is also linked to stomach problems and yeast infections. And the more antibiotics are used, the more strains of bacteria and diseases become immune to treatment with antibiotics. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, researchers from the University of Toronto and the University of Alberta reviewed previous studies focusing on antibiotic stewardship programs implemented in hospitals through May 2023. The stewardship programs used various techniques, like doctor oversight, to reduce antibiotic use or reduce prescription duration. The review included data from 70 studies including more than 350,000 infants. The data indicates that implementing antibiotic stewardship programs helped reduce new antibiotic prescriptions in NICUs by 19% on average, with rates ranging from 14% to 24% across various hospitals and programs. The programs reduced new prescriptions by 8% on average among NICUs and postnatal wards, ranging from 6% to 10% overall. Stewardship programs also helped to reduce the overall duration of antibiotic use by an average pf 20%, ranging from 10% in some hospitals and up to 30% in others. The programs helped to reduce the length of antibiotic therapy by 1.82 days on average but up to 2.65 days in some cases. Stewardship programs also helped to reduce the use of longer courses of antibiotic prescriptions that were greater than five days by 9%. Researchers determined the study data showed that the programs helped to reduce antibiotic overuse and prescription duration, but they also helped to reduce restarting antibiotic courses. The findings indicated there was no increase in side effects or risk of death. Researchers said, overall, the stewardship intervention programs were successful in helping to improve the safe and responsible use of antibiotics among infants in NICUs, which can translate to a long-term positive impact on reducing antibiotic-resistant bacteria. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Antibiotic Resistance, Antibiotics, Hospital, Infant, Infections, NICU Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Abbott Seeks Federal Protection From Similac NEC Lawsuits December 16, 2025 Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 3 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025) Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 4 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025) Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 5 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 3 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 4 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)
Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 5 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)